Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.
about
VNI cures acute and chronic experimental Chagas diseaseChagas' disease and the autoimmunity hypothesis.Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.Alterations in production of immunoglobulin classes and subclasses during experimental Trypanosoma cruzi infection.Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice.Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' diseaseTrypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytesBinding of the specific ligand to Fc receptors on Trypanosoma cruzi increases the infective capacity of the parasiteSuppression of human lymphocyte responses by Trypanosoma cruziTrypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infectionOn evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease
P2860
Q24604994-6831B64F-353C-4846-B9CB-D1250B06E48CQ33588893-2E5A488D-82FE-41F5-BC7D-EF8672A7FF06Q35099742-0357D56B-F962-4FD2-B0EF-89A638D3EE96Q35519006-9EDCFC28-F920-43E4-9BC2-1861BA380003Q35746981-9C158EB7-BFE7-4E2F-B306-D3F925B715A1Q35856418-96DBDA6F-55A6-4A0C-A7D8-87573E6F004CQ37099632-20A069F1-E536-4FEC-B9F0-7B3820CF4AEDQ38819127-AC978B07-CBF5-4D0E-9F0B-F1A5CFBA5798Q39825831-80EC6760-F120-4CE3-9021-674121713892Q58844003-130B7C04-DFB6-40F9-9E7B-8E38ABE14812Q58844763-F87DC942-EFF3-4AEA-BC40-2A78C8E64ECEQ58844966-9A00A821-DD89-431C-9EA7-B9ED6B4BB829Q58846120-201F9C0E-D20A-40B6-9ED5-2C7CBD6FCA7EQ58846869-A5AD67F6-A091-49F5-A141-DA079A69505DQ58847586-E8DA474B-435C-4643-8B82-00F0DA63F01C
P2860
Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@ast
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@en
type
label
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@ast
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@en
prefLabel
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@ast
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@en
P2860
P1476
Experimental Chagas' disease: ...... c Trypanosoma cruzi infection.
@en
P2093
F Kierszenbaum
P2860
P304
P407
P577
1981-03-01T00:00:00Z